Skip to content

Clinical trials

Hematologic Neoplasms trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hematologic Neoplasms Country / region: Germany Clear all

64 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20031
20041
20061
20072
20093
20101
20115
20123
20132
20142
20151
20163
20174
20181
20192
20206
20218
20224
20234
20242
20252
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed26
Recruiting16
Active, not recruiting7
Terminated6
Unknown status6
Enrolling by invitation3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Kiadis Pharma5
Novartis Pharmaceuticals4
AstraZeneca3
Bristol-Myers Squibb3
Merck Sharp & Dohme LLC3
University Hospital Tuebingen3
Fred Hutchinson Cancer Center2
Janssen Research & Development, LLC2
Kura Oncology, Inc.2
Munich Leukemia Laboratory2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hematologic Neoplasms64
Leukemia, Myeloid, Acute13
Leukemia12
Multiple Myeloma10
Myelodysplastic Syndromes9
Neoplasms8
Precursor Cell Lymphoblastic Leukemia-Lymphoma8
Leukemia, Lymphocytic, Chronic, B-Cell7
Lymphoma7
Graft vs Host Disease6

Trials

Showing 51 to 64 of 64. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.